Vyro Bio

0 followers


Vyro develops oncolytic viruses designed to target CNS tumors, based on pioneering research on the oncolytic properties of the Zika Virus.

Industries

Headquarters

São Paulo, Brazil

Employees

11-50

Links


Org chart

Hugo Cabrera
CEO & Co-Founder
Collapse
No reports!

Board & advisors

Ernesto Goulart
Co-Founder
Keith Okamoto
Cofounder & Board Member
Mayana Zatz
Co-founder & Scientific Advisor
Jorge Kalil
Board Member
Harry Bulstrode
Scientific Advisor
Marcia De Souza Lima
Scientific Advisor
Caroline Chaul
Medical Advisor